Classification of cutaneous malignant melanoma: A reassessment of histopathologic criteria for the distinction of different types

Cancer

Volumn 86, Issue 2, 1999, Pages 288-299

  Weyers, Wolfgang ^a,c   Euler, Matthias ^b   Diaz Cascajo, Carlos ^a   Schill, Wolf Bernhard ^b   Bonczkowitz, Matthias ^b  

^a Center for Dermatopathology   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c Center for Dermatopathology   (Germany)

Author keywords

Acral lentiginous melanoma; Classification; Lentigo maligna melanoma; Malignant melanoma; Nodular melanoma; Superficial spreading melanoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; ELASTOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCHOOL CHILD; SUPERFICIAL CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS;

EID: 0033565416     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990715)86:2<288::AID-CNCR13>3.0.CO;2-S     Document Type: Article

References (45)

1. Mishima Y, Matsunaka M. Pagetoid premalignant melanosis and melanoma: differentiation from Hutchinson's melanotic freckle. J Invest Dermatol 1975;65:434-40.
2. Weiss J, Bertz J, Jung EG. Malignant melanoma in southern Germany: different predictive value of risk factors for melanoma subtypes. Dermatologica 1991;183:109-13.
3. Clark WH Jr., Ainsworth AM, Bernardino EA, Yan CH, Mihm MC, Reed RJ. The developmental biology of primary human malignant melanomas. Semin Oncol 1975;2:83-103.
4. Elwood JM, Gallagher RP, Worth AJ, Wood WS, Pearson JCG. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada melanoma study. J Natl Cancer Inst 1987;78:37-44.
5. Feibleman CE, Stoll H, Maize JC. Melanomas of the palm, sole, and nailbed: a clinicopathologic study. Cancer 1980;46: 2492-504.
6. Clark WH Jr., Elder DE, Guerry D IV, Epstein MN, Greene MH, Van Horn M. A study of tumor progression. The precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984;15:1147-65.
7. Koh HK, Michalik E, Sober AJ, Lew RA, Day CL, Clark WH, et al. Lentigo maligna melanoma has no better prognosis than other types of melanoma. J Clin Oncol 1984;2:994-1001.
8. Soøndergaard K, Schou G. Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. Virchows Arch A Pathol Anat Histopathol 1985;406:179-95.
9. Balch CM, Soong SJ, Shaw HM, Milton GW. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong AJ, editors. Cutaneous melanoma. 2nd edition. Philadelphia: J.B. Lippincott, 1992:165-87.
10. Ringborg U, Afzelius LE, Lagerlöf B, Adami HO, Augustsson I, Blomqvist E, et al. Cutaneous malignant melanoma of the head and neck. Cancer 1993;71:751-8.
11. Cox NH, Aitchison TC, Sirel JM, MacKie RM. Comparison between lentigo malignant melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group. Br J Cancer 1996;73:940-4.
12. Ackerman AB. Malignant melanoma: a unifying concept. Hum Pathol 1980;11:591-5.
13. Ackerman AB, David KM. A unifying concept of malignant melanoma: biologic aspects. Hum Pathol 1986;17:438-40.
14. Clark WH Jr., From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969;29:705-26.
15. McGovern VJ. The nature of melanoma: a critical review. J Cutan Pathol 1982;9:61-81.
16. Clark WH Jr., Elder DE, Guerry D. Dysplastic nevi and malignant melanoma. In: Farmer ER, Hood AF, editors. Pathology of the skin. East Norwalk, CT: Appleton and Lange, 1990:684-756.
17. Barnhill RL, Mihm MC. Histopathology of malignant melanoma and its precursor lesions. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong AJ, editors. Cutaneous melanoma. 2nd edition. Philadelphia: J.B. Lippincott, 1992:234-63.
18. Mihm MC Jr., Googe PB. Problematic pigmented lesions. A case method approach. Philadelphia: Lea and Febinger, 1990.
19. Tersteegen A, Steigleder GK. Ist der Befall der Hautadnexe oder die Dicke der Epidermis eine Hilfe bei der Differential-diagnose zwischen Lentigo maligna Melanom (LMM) und Superfiziell Spreitendem Melanom in situ (SSM)? Z Hautkr 1990;65:941-2.
20. Reed RJ. New concepts in surgical pathology of the skin. New York: John Wiley and Sons, 1976.
21. Cascinelli N, Zurrida S, Galimberti V, Bartoli C, Bufalino R, Del Prato I, et al. Acral lentiginous melanoma. A histological type without prognostic significance. J Dermatol Surg Oncol 1994;20:817-22.
22. Arrington JH, Reed RJ, Ichinose H, Krementz ET. Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol 1977;1:130-43.
23. Coleman WP, Loria PR, Reed RJ, Krementz ET. Acral lentiginous melanoma. Arch Dermatol 1980;116:773-6.
24. Lopansri S, Mihm MC Jr. Clinical and pathologic correlation of malignant melanoma. J Cutan Pathol 1979;6:180-94.
25. Kerl H, Hödl S, Stettner H. Acral lentiginous melanoma. In: Ackerman AB, editor. Pathology of malignant melanoma. New York: Masson, 1981:217-42.
26. Corona R, Mele A, Amini M, De Rosa G, Coppola G, Piccardi P, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 1996;14:1218-23.
27. Ackerman AB, David KM. A unifying concept of malignant melanoma. Hum Pathol 1986;17:438-40.
28. Goldsmith LA, Askin FB, Chang AE, Cohen C, Dutcher JP, Gilgor RS, et al. National Institute of Health Consensus Development Conference statement on diagnosis and treatment of early melanoma. Am J Dermatopathol 1993;15:34-43.
29. Ho VC, Sober AJ. Therapy for cutaneous melanoma: an update. J Am Acad Dermatol 1990;22:159-76.
30. Mussack T, Waldner H, Kharraz-Tavakol A. Risikofaktoren für die Lymphknotenmetastasierung beim malignen Melanom. Zentralbl Chir 1996;121:465-8.
31. Lee CS, Pirdas A, Lee MW. P53 in cutaneous melanoma: immunoreactivity and correlation with prognosis. Australas J Dermatol 1995;36:192-5.
32. Jafari M, Papp T, Kirchner S, Diener U, Henschler D, Burg G, et al. Analysis of ras mutation in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma. J Cancer Res Clin Oncol 1995;121:23-30.
33. Van Elsas A, Zerp SF, Van der Flier S, Kruse KM, Aarnoudse C, Hayward NK, et al. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol 1996;149:883.
34. Weyers W. Circumscribed precancerous melanosis of Dubreuilh. Dermatopathol Pract Concept 1997;3:157-65.
35. Weyers W. Excision of melanoma in historical perspective; triumph of irrationality for nearly a century. Dermatopathol Pract Concept 1997;3:238-46.
36. Hunter JA, Zaynoun S, Paterson WD, Bleehen SS, MacKie R, Cochran AJ. Cellular fine structure in the invasive nodules of different histogenetic types of melanoma. Br J Dermatol 1978;98:255-72.
37. Jimbow K, Salopek TG, Dixon WT, Searles GE, Yamada K. The epidermal melanin unit in the pathophysiology of malignant melanoma. Am J Dermatopathol 1991;13:179-88.
38. Haensch R. Tyrosinase activity in three types of the malignant melanoma: superficial spreading melanoma, lentigo maligna melanoma and nodular melanoma. Arch Dermatol Forsch 1975;252:193-201.
39. Paul E. Histochemical findings in different types of malignant melanoma: biological and clinical significance. Arch Dermatol Forsch 1975;254:159-74.
40. Ellis DL, Wheeland RG, Solomon H. Estrogen and progesterone receptors in primary cutaneous melanoma. J Dermatol Surg Oncol 1985;11:54-9.
41. Müller-Eckhardt G, Schendel DJ, Hundeiker M, Riedel T, O'Neill GJ, Riethmüller G, et al. Possible association between HLA-DR5 and superficial spreading melanoma (SSM). Int J Cancer 1984;34:751-5.
42. Yamamura K, Mishima Y. Antigen dynamics in melanocytic and nevocytic melanoma oncogenesis. J Invest Dermatol 1990;94:174-82.
43. Weiss J, Heine M, Korner B, Pilch H, Jung EG. Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications. Br J Dermatol 1995;133:23-31.
44. Sober AJ, Fitzpatrick TB, editors. Year book of dermatology. Chicago: Year Book Medical Publishers, 1988.
45. Kelly JW. Following lentigo maligna may not prevent the development of life-threatening melanoma. Arch Dermatol 1992;128:657-60.